FDA Approves Simplera Otic Solution to Treat Ear Infections in Dogs

U.S. Food and Drug Administration sent this bulletin at 09/28/2022 11:03 AM EDT

If your email program has trouble displaying this email, view as a webpage.
US Food and Drug Administration

FDA Approves Simplera Otic Solution to Treat Ear Infections in Dogs

Today the U.S. Food and Drug Administration approved Simplera Otic Solution, the first generic drug product that has a single dose treatment with a 30-day duration of effect for otitis externa (outer ear infection) in dogs associated with susceptible strains of yeast (Malassezia pachydermatis) and bacteria (Staphylococcus pseudintermedius).

Read More Button


You are subscribed to updates from FDA's Center for Veterinary Medicine.